The human platelet is an important component in the pathophysiology of several immunohematologic disorders.
The aim of this research proposal is to study the platelet receptors for the Fc fragment of IgG and to study the interaction of human complement with platelets. We will study the nature of the interaction between radiolabeled IgG ligand and its platelet binding site and examine the modulation of this interaction by plasma proteins (Hageman factor, C3b, fibronectin) and other molecules present during inflammation (variation interferon). We will isolate and characterize the platelet Fc (IgG) binding site and produce antibodies to epitopes on this receptor. We will explore whether the expression of this receptor is altered in immune thrombocytopenic purpura (ITP), ITP associated with systemic lupus erythematosis and heparin-associated thrombocytopenia. Immune complex-platelet Fc (IgG) receptor interactions likely play a role in the pathophysiology of these disorders. We will evaluate the effect of glucocorticoids, danazol and vinblastine on platelet Fc (IgG) receptor expression in ITP and ITP associated with systemic lupus, as these drugs may mediate their activity, in part, by an effect on this receptor. Complement platelet interactions play a role in immune platelet disorders and may predispose to thrombosis. Complement will be activated by platelet alloantibidy, heparin-dependent antibody, complement dependent ITP autoantibody, and oligomeric IgG bound to the platelet Fc (IgG) receptor. We will explore possible mechanisms by which complement-platelet interactions amy lead to thrombosis by determinin the precise complement components necessary to activate platelets and to increase platelet responsiveness to ADP. Furthermore, we will begin studies aimed at identifying the locus of complement deposition in the platelet membrane. We will extend our studies in ITP and pregnancy, ITP caused by IgM antibody and complement, and on the mechanisms of action of glucocorticoids and their analogues. We will study the effect of steroid analogues on the platelet Fc (IgG) receptor, on platelet-complement interaction and on immune clearance. These studies should be helpful in elucidating the pathogenesis of, and several of the abnormalities observed in, immune platelet disorders and immunohematologic disease. Furthermore, they should be helpful in developing approaches for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL028207-07
Application #
3485925
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1981-12-01
Project End
1991-11-30
Budget Start
1987-12-01
Budget End
1988-11-30
Support Year
7
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Vieth, Joshua A; Kim, Moo-kyung; Glaser, Daniel et al. (2013) Fc?RIIa requires lipid rafts, but not co-localization into rafts, for effector function. Inflamm Res 62:37-43
Worth, Randall G; Chien, Christopher D; Chien, Paul et al. (2006) Platelet FcgammaRIIA binds and internalizes IgG-containing complexes. Exp Hematol 34:1490-5
Worth, R G; Mayo-Bond, L; Kim, M K et al. (2001) The cytoplasmic domain of FcgammaRIIA (CD32) participates in phagolysosome formation. Blood 98:3429-34
Kim, M K; Pan, X Q; Huang, Z Y et al. (2001) Fc gamma receptors differ in their structural requirements for interaction with the tyrosine kinase Syk in the initial steps of signaling for phagocytosis. Clin Immunol 98:125-32
Marshall, J G; Booth, J W; Stambolic, V et al. (2001) Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fc gamma receptor-mediated phagocytosis. J Cell Biol 153:1369-80
Sato, N; Kim, M K; Schreiber, A D (1999) Enhancement of fcgamma receptor-mediated phagocytosis by transforming mutants of Cbl. J Immunol 163:6123-31
Pan, X Q; Darby, C; Indik, Z K et al. (1999) Activation of three classes of nonreceptor tyrosine kinases following Fc gamma receptor crosslinking in human monocytes. Clin Immunol 90:55-64
Matsuda, M; Park, J G; Wang, D C et al. (1996) Abrogation of the Fc gamma receptor IIA-mediated phagocytic signal by stem-loop Syk antisense oligonucleotides. Mol Biol Cell 7:1095-106
Indik, Z K; Park, J G; Pan, X Q et al. (1995) Induction of phagocytosis by a protein tyrosine kinase. Blood 85:1175-80
Park, J G; Schreiber, A D (1995) Determinants of the phagocytic signal mediated by the type IIIA Fc gamma receptor, Fc gamma RIIIA: sequence requirements and interaction with protein-tyrosine kinases. Proc Natl Acad Sci U S A 92:7381-5

Showing the most recent 10 out of 27 publications